Novartis drug approved by EU
Article Abstract:
Swiss pharmaceutical firm Novartis AG received approval by the European Union to market a generic version of epoetin alfa, an anti-anemia drug, in Europe. The non-generic version, Eprex, is marketed in Europe by Johnson and Johnson.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
Europe, Product introduction, New Products/Services, Generic Drugs, Hematinic Preparations, European Union, Erythropoietin, Recombinant, Hematinics, Epoetin alfa
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Novartis has potential blockbuster as FDA backs blood-pressure drug
Article Abstract:
The U.S. Food and Drug Administration has approved Swiss pharmaceutical company Novartis AG's blood pressure drug, Tekturna. This approval could result in billions of dollars of sales for Novartis.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
United States, Blood Pressure Preparations, United States. Food and Drug Administration, Antihypertensive drugs, Antihypertensive agents, Tekturna (Medication)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Pharmaceutical industry, Switzerland, Novartis AG, Licensing, certification and accreditation, NVTSY
Similar abstracts:
- Abstracts: Novartis comes to rescue of neurotic dogs. U.S. approves Glaxo treatment for depression. AstraZeneca's Crestor should get U.S. approval
- Abstracts: Novartis offers to buy rest of Chiron. Novartis agrees to acquire the rest of Chiron for $5.1 billion. Biotech industry heads toward IPO boomlet
- Abstracts: North Korea's block on food aid reflects regime push for control
- Abstracts: IT job growth is seen slowing for rest of year. As U.S. trade deficit narrows, prospects brighten for economy
- Abstracts: Belgacom unit in France to cut phone rates. Tailoring ads to email users, Google has some poor fits. Sony's new videogame camera posts strong sales in Europe
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.